Collplant Biotechnologies Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CLGN Nasdaq 8731 https://www.collplant.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Collplant Biotechnologies Ltd

CollPlant Issues Letter to Shareholders - Jan 24th, 2023 12:00 pm
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives - Jan 4th, 2023 12:00 pm
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form - Jan 3rd, 2023 12:00 pm
We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth - Dec 12th, 2022 2:50 pm
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results - Dec 1st, 2022 12:00 pm
CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis - Nov 15th, 2022 12:00 pm
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90 - Nov 7th, 2022 12:00 pm
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17 - Nov 3rd, 2022 11:00 am
CollPlant to present at the Dawson James Small Cap Growth Conference on October 12 - Oct 3rd, 2022 11:00 am
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy - Sep 19th, 2022 11:00 am
CollPlant Biotechnologies to Participate in September Investor Conferences - Sep 6th, 2022 11:00 am
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results - Aug 25th, 2022 11:00 am
We're Hopeful That CollPlant Biotechnologies (NASDAQ:CLGN) Will Use Its Cash Wisely - Jul 5th, 2022 2:27 pm
CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada - Jul 5th, 2022 11:00 am
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study - Jun 29th, 2022 12:45 pm
CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results - May 26th, 2022 11:00 am
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman - May 23rd, 2022 12:00 pm
The 22% return this week takes CollPlant Biotechnologies' (NASDAQ:CLGN) shareholders three-year gains to 141% - May 21st, 2022 12:59 pm
CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening - Apr 25th, 2022 11:00 am
CollPlant To Present at the Aesthetics Innovation Summit 2022 - Apr 13th, 2022 11:00 am